FindTrial
Sign In

To measure serum prolactin levels in Obese patients with type 2 Diabetes mellitus and to infer its association with cardiovascular complications.

Prolactin levels in Obese type 2 Diabetes mellitus patients and its association with Carotid intima media thickness. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/08/072382
Enrollment
224
Registered
2024-08-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: E116- Type 2 diabetes mellitus with other specified complications Health Condition 3: E116- Type 2 diabetes mellitus with other specified complications

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients more than 18 years of age. 2. Patients with Type 2 Diabetes mellitus and Obesity.

Exclusion criteria

Exclusion criteria: 1. Pregnant females. 2. Patients less than 18 years of age.

Design outcomes

Primary

MeasureTime frame
To determine the levels of Prolactin in Obese Type 2 Diabetes mellitus patients.Timepoint: Prolactin levels will be assessed during the first visit of the patient.—

Secondary

MeasureTime frame
To determine the association between Prolactin levels & carotid intimal medial thickness in Obese patients with Type 2 Diabetes mellitus.Timepoint: Prolactin levels & carotid intima media thickness shall be measured on the first visit. Each patient prolactin level will be correlated with their carotid intima & medial thickness on the first visit itself. No follow up is needed further in this study.—

Countries

India

Contacts

Public ContactDr Preeti Singh Dhoat

AIIMS Bathinda

drpreetidhoat@gmail.com7888849499

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026